Nipent pentostatin: Phase IV ongoing

Data from an ongoing, open-label, U.S. Phase IV trial in 33 patients showed that

Read the full 143 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE